Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again
Wednesday, April 3, 2019 - 10:20
in Health & Medicine
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.